HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Henrik Clausen Selected Research

Polypeptide N-acetylgalactosaminyltransferase

6/2012Probing isoform-specific functions of polypeptide GalNAc-transferases using zinc finger nuclease glycoengineered SimpleCells.
3/2012Elucidation of the sugar recognition ability of the lectin domain of UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 3 by using unnatural glycopeptide substrates.
2/2010Loss of UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 3 and reduced O-glycosylation in colon carcinoma cells selected for hepatic metastasis.
1/2007Immunolocalisation of members of the polypeptide N-acetylgalactosaminyl transferase (ppGalNAc-T) family is consistent with biologically relevant altered cell surface glycosylation in breast cancer.
7/2006Polypeptide GalNAc-transferase T3 and familial tumoral calcinosis. Secretion of fibroblast growth factor 23 requires O-glycosylation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Henrik Clausen Research Topics

Disease

50Neoplasms (Cancer)
01/2022 - 06/2003
13Carcinoma (Carcinomatosis)
10/2020 - 06/2003
11Breast Neoplasms (Breast Cancer)
01/2015 - 12/2002
9Adenocarcinoma
11/2016 - 03/2008
6Pancreatic Neoplasms (Pancreatic Cancer)
10/2021 - 03/2008
6Neoplasm Metastasis (Metastasis)
01/2021 - 02/2010
5Ovarian Neoplasms (Ovarian Cancer)
10/2020 - 05/2014
3Carcinogenesis
10/2021 - 10/2004
3Hyperphosphatemia
01/2020 - 11/2011
3Calcinosis
01/2020 - 07/2006
3Colorectal Neoplasms (Colorectal Cancer)
05/2016 - 04/2011
2Thrombocytopenia (Thrombopenia)
12/2021 - 08/2009
2Congenital Disorders of Glycosylation
01/2018 - 02/2015
2Stomach Neoplasms (Stomach Cancer)
06/2015 - 03/2013
2IGA Glomerulonephritis (IGA Nephropathy)
11/2014 - 03/2013
2Multiple Myeloma
05/2014 - 11/2006
2Disease Progression
04/2013 - 10/2010
2Metaplasia
04/2013 - 01/2011
2Hyperostosis
12/2012 - 11/2011
2Prostatic Neoplasms (Prostate Cancer)
02/2010 - 12/2007
1Respiratory Tract Diseases (Respiratory Tract Disease)
01/2022
1Glioblastoma (Glioblastoma Multiforme)
01/2022
1Leukemia
01/2022
1Arthritis (Polyarthritis)
01/2022
1Influenza in Birds (Avian Flu)
01/2022
1Type 2 Diabetes Mellitus (MODY)
10/2021
1Alzheimer Disease (Alzheimer's Disease)
01/2021
1Lymphoma (Lymphomas)
01/2021
1B-Cell Lymphoma (Lymphoma, B Cell)
01/2021
1Liver Neoplasms (Liver Cancer)
11/2020

Drug/Important Bio-Agent (IBA)

22Polysaccharides (Glycans)IBA
10/2021 - 10/2004
20MucinsIBA
01/2022 - 06/2003
17AntigensIBA
01/2020 - 06/2003
16Glycoproteins (Glycoprotein)IBA
10/2021 - 06/2005
14Proteins (Proteins, Gene)FDA Link
01/2022 - 12/2002
13EpitopesIBA
01/2022 - 06/2003
12Biomarkers (Surrogate Marker)IBA
10/2020 - 02/2010
11GlycopeptidesIBA
01/2020 - 02/2006
10AntibodiesIBA
01/2022 - 10/2003
8Mucin-1 (CA 15-3 Antigen)IBA
01/2016 - 10/2004
7Peptides (Polypeptides)IBA
01/2020 - 06/2003
7GlycosyltransferasesIBA
01/2018 - 06/2003
7VaccinesIBA
11/2015 - 10/2003
6CarbohydratesIBA
01/2020 - 06/2003
6Monoclonal AntibodiesIBA
05/2014 - 05/2005
5LectinsIBA
10/2020 - 10/2009
5Chimeric Antigen ReceptorsIBA
01/2020 - 01/2016
5AutoantibodiesIBA
05/2014 - 02/2010
5Polypeptide N-acetylgalactosaminyltransferaseIBA
06/2012 - 07/2006
4Galactose (Galactopyranose)FDA LinkGeneric
10/2020 - 09/2007
4Tumor Viral Antigens (Large T Antigen)IBA
01/2019 - 10/2009
4EnzymesIBA
01/2019 - 01/2011
4keyhole-limpet hemocyanin (keyhole limpet hemocyanin)IBA
12/2007 - 10/2003
3SialyltransferasesIBA
01/2022 - 02/2006
3Protein Isoforms (Isoforms)IBA
01/2021 - 03/2012
3Sialyl Lewis X AntigenIBA
01/2021 - 07/2012
3C-Type Lectins (C-Type Lectin)IBA
10/2020 - 09/2007
3Surface Antigens (Surface Antigen)IBA
01/2020 - 10/2003
3Tn antigenIBA
01/2020 - 01/2007
3AcetylgalactosamineIBA
01/2020 - 04/2012
3Biological ProductsIBA
07/2018 - 01/2007
3Tumor Biomarkers (Tumor Markers)IBA
11/2015 - 02/2015
3DisaccharidesIBA
10/2009 - 05/2005
3saponin QA-21V1 (QS21)IBA
12/2007 - 05/2005
2Indicators and Reagents (Reagents)IBA
01/2022 - 08/2010
2GemcitabineFDA Link
10/2021 - 01/2021
2SugarsIBA
10/2020 - 01/2020
2Cadherins (E-Cadherin)IBA
01/2020 - 12/2013
2Membrane Proteins (Integral Membrane Proteins)IBA
01/2020 - 08/2013
2Threonine (L-Threonine)FDA Link
01/2020 - 05/2005
2Serine (L-Serine)FDA Link
01/2020 - 05/2005
2AutoantigensIBA
01/2016 - 03/2008
2Immunoglobulin A (IgA)IBA
11/2014 - 03/2013
2Transcription Factors (Transcription Factor)IBA
12/2013 - 05/2012
2CA-19-9 Antigen (CA 19-9 Antigen)IBA
04/2013 - 07/2012
2Carbohydrate Tumor-Associated Antigens (Antigens, Tumor-Associated Carbohydrate)IBA
04/2013 - 07/2012
2sialosyl-Tn antigenIBA
01/2011 - 10/2004
2MonosaccharidesIBA
12/2010 - 05/2005
2GlycoconjugatesIBA
10/2009 - 10/2005
2TransferasesIBA
01/2007 - 06/2003
2SaponinsIBA
05/2005 - 10/2003
1monomethyl auristatin EIBA
01/2022
1Immunoconjugates (Immunoconjugate)IBA
01/2022
1sialic acid receptorIBA
01/2022
1podocalyxinIBA
01/2022
1Heparin (Liquaemin)FDA LinkGeneric
12/2021
1Platelet Factor 4IBA
12/2021
1AnticoagulantsIBA
12/2021
1Insulin (Novolin)FDA Link
10/2021
1NucleosidesIBA
10/2021
1ErbB Receptors (EGF Receptor)IBA
01/2021
1LigandsIBA
01/2021
1CytokinesIBA
01/2021
1E-SelectinIBA
01/2021
1SelectinsIBA
01/2021
1Sialic Acid Binding Ig-like Lectin 3IBA
01/2021
1CalnexinIBA
11/2020

Therapy/Procedure

6Therapeutics
01/2021 - 11/2006
4Immunotherapy
04/2013 - 02/2006
3Ligation
06/2015 - 07/2012